Posts Tagged: CIRM
News
The folks who are trying to save the $3 billion California stem cell agency from financial extinction are using a well-worn technique that goes back to ancient Egypt, at least by some accounts. It is expensive, depending on what you are peddling, and generates a return as low as 1 percent. It is direct mail, but with a significant twist.
News
California’s stem cell agency, in an emergency action, has allocated $5 million for research into treatments for Covid-19 and set the deadline for the first applications for one week from today. The California Institute for Regenerative Medicine (CIRM) approved the funding Friday during an emergency meeting of its governing board.
News
Backers of a California ballot initiative to provide $5.5 billion more for the state’s cash-strapped stem cell agency say they will take their first official step by the end of this month.That’s when they will submit the proposed measure to California election officials and trigger a many-months-long process. The effort is aimed at ensuring that the nearly 15-year-old research effort survives in a meaningful way beyond next year.
News
The $3 billion California stem cell agency on Monday served up the bad news with only a smattering of sugar coating. No more applications for research funding are being accepted. The cash is running out, perhaps as early as the end of August.
News
The $3 billion California stem cell agency, which is running out of cash, has served notice that it would stop accepting applications for more research awards beginning next month. The low key announcement on Thursday is another step towards the looming demise of the 14-year-old agency, created by voters in November 2004.
News
The man expected to lead the drive for $5.5 billion more for California’s stem cell agency today said the Trump restrictions on fetal tissue research represent a dangerous precedent that threatens the health of all Americans.
News
The man regarded as the father of the $3 billion California stem cell agency is thinking about changes in the program to help win voter approval of another $5 billion for the research program. They include a stronger requirement to make state-backed, stem cell therapies more affordable and accessible and to provide more cash for creating a greater stem cell work force in the Golden State.
News
In just nine days, the California stem cell agency will take a close look at its future, examining its budget for the coming fiscal year as well as the possibilities for a ballot initiative in 2020 that could stave off its financial demise. The $3 billion enterprise, known formally as the California Institute for Regenerative Medicine (CIRM), expects to run out cash for new research awards this year, perhaps as early as September.
News
The California stem cell agency has doubled down on its bet on a potentially breakthrough treatment for kidney transplants, raising to $25.4 million its support for a project that is entering its final stages. The hope is that the treatment will not only improve the success rate of kidney transplants but also lead to use in liver, heart and other solid organ transplants.
News
Facing the likelihood of a slow and withering death, the California stem cell agency is edging gingerly forward on a path of “cuts” and risky fund-raising in hopes that its research results will soon generate voter support for more billions of dollars. Two governing board committees of the $3 billion agency, formally known as the California Institute for Regenerative Medicine (CIRM), on Monday. Nov. 27, recommended that the full board “entertain” the proposals at its Dec. 14 meeting.
Robert Klein, who spent six years as the state stem cell agency's chairman, addresses issues related to the November ballot initiative. (Photo: David Jensen, California Stem Cell Report)
